Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma

• Main Authors: Ha‐Yeon Shin, Wookyeom Yang, Doo Byung Chay, Eun‐ju Lee, Joon‐Yong Chung, Hyun‐Soo Kim, Jae‐Hoon Kim
• Format: Article
• Language: English
• Published: Wiley 2021-04-01
• Series: Molecular Oncology
• Subjects: AMP‐activated protein kinase; atypical endometriosis; endometriosis; ovarian clear cell carcinoma; tetraspanin 1
• Online Access: https://doi.org/10.1002/1878-0261.12884

Ovarian clear cell carcinoma (OCCC) reportedly develops from endometriosis. However, the molecular mechanism underlying its malignant progression to OCCC remains elusive. This study aimed to identify an essential gene in the malignant transformation of endometriosis to OCCC. We performed RNA sequencing in formalin‐fixed, paraffin‐embedded (FFPE) tissues of endometriosis (n = 9), atypical endometriosis (AtyEm) (n = 18), adjacent endometriosis to OCCC (AdjEm) (n = 7), and OCCC (n = 17). We found that tetraspanin 1 (TSPAN1) mRNA level was significantly increased by 2.4‐ (DESeq2) and 3.4‐fold (edgeR) in AtyEm and by 80.7‐ (DESeq2) and 101‐fold (edgeR) in OCCC relative to endometriosis. We confirmed that TSPAN1 protein level was similarly overexpressed in OCCC tissues and cell lines. In immortalized endometriosis cell lines, TSPAN1 overexpression enhanced cell growth and invasion. Mechanistically, TSPAN1 triggered AMP‐activated protein kinase (AMPK) activity, promoting endometriosis and cell growth. Upregulated levels of TSPAN1 are considered an early event in the development of high‐risk endometriosis that could progress to ovarian cancer. Our study suggests the potential of TSPAN1 as a screening candidate for high‐risk endometriosis.